Poolbeg Pharma PLC (POLB) — Cash Flow-to-Debt Ratio
Poolbeg Pharma PLC (POLB) has a Cash Flow-to-Debt Ratio of -1.61x as of December 2025, meaning its operating cash flow of GBX-2.16 Million could theoretically repay -2% of its total liabilities (GBX1.34 Million) in one year. See working capital to net assets of Poolbeg Pharma PLC to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Poolbeg Pharma PLC Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for Poolbeg Pharma PLC across 5 annual periods. Also explore Poolbeg Pharma PLC equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Poolbeg Pharma PLC (2021–2025)
Year-by-year debt coverage analysis for Poolbeg Pharma PLC. For market capitalisation and broader financial context, see Poolbeg Pharma PLC market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.36x | GBX-4.51 Million | GBX1.34 Million | ▲ +29.5% |
| 2024 | -4.77x | GBX-4.65 Million | GBX974.00K | ▼ -7.4% |
| 2023 | -4.44x | GBX-4.38 Million | GBX986.00K | ▲ +1.7% |
| 2022 | -4.52x | GBX-4.37 Million | GBX966.00K | ▲ +7.7% |
| 2021 | -4.90x | GBX-2.15 Million | GBX438.00K | — |